What You Should Know:
- MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on "deep health" solutions that address diseases linked to environmental toxins and synthetic exposures.
- Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that move beyond symptom management
Read More
Tampa General Hospital Partners with Reimagine Care to Launch AI-Enabled Virtual Oncology Support
What You Should Know:
- Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
- The collaboration, backed by an investment from TGH Ventures, provides 24/7 symptom monitoring and triage to reduce emergency department visits and administrative burden on oncologists. This move aims to expand capacity and improve patient outcomes across Florida, a state facing 115,000 new
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know:
- Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform.
- The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips' existing portfolio.
- The strategic expansion aims to
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
Mount Sinai’s AI Tool “V2P” Predicts Disease Type from Genetic Mutations
What You Should Know:
- Scientists at the Icahn School of Medicine at Mount Sinai have developed a new artificial intelligence tool called V2P (Variant to Phenotype) that identifies not only disease-causing genetic mutations but also predicts the specific diseases they may trigger.
- Published in Nature Communications, this machine learning model improves diagnostic speed and accuracy by linking genetic variants to phenotypic outcomes, moving beyond simple "harmful vs. benign"
Read More
M&A: Sentact Acquires Performance Health Partners and Vizient PSO to Create Patient Safety Powerhouse
What You Should Know:
- Sentact has executed a major strategic expansion by acquiring two significant players in the patient safety space: Performance Health Partners (PHP), the #1 Best-in-KLAS provider of safety incident management software, and the Vizient Patient Safety Organization (PSO), one of the nation's largest PSOs.
- The double acquisition positions Sentact to offer a comprehensive, end-to-end safety platform that combines top-tier incident reporting technology with
Read More
Deloitte 2026 Outlook: Why Traditional Health Strategies Will Fail in the Face of Regulatory Uncertainty
What You Should Know:
- Deloitte’s 2026 US Health Care Outlook reveals a dangerous disconnect: while nearly 70% of health executives expect to outperform competitors next year, the "traditional playbook" of market expansion and cost-cutting is no longer sufficient.
- Amid rising regulatory uncertainty and financial pressure, the report identifies three mandatory pivots for survival: empowering consumer health with digital experiences, scaling generative and agentic AI across
Read More
The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags
What You Should Know:
- A new report from Sage Growth Partners reveals a striking disconnect in the healthcare industry: while only 20% of C-suite leaders believe progress has been made in value-based care (VBC) recently, 77% plan to increase their participation in these models over the next two years.
- The "plot twist" indicates that despite operational hurdles and low revenue exposure today, hospital executives view VBC as essential for long-term financial survival. The data
Read More
FDA Clears Ceribell’s AI-Powered EEG as First Device for Continuous Delirium Monitoring
What You Should Know:
- Ceribell, Inc. has secured FDA 510(k) clearance for the world’s first continuous, AI-powered delirium monitoring solution, expanding its existing EEG platform beyond seizure detection.
- The technology addresses a massive gap in critical care, providing objective, real-time tracking for a condition that affects up to 80% of ventilated patients and is often missed by manual assessments. The clearance positions Ceribell to significantly improve ICU
Read More
